Edition:
United Kingdom

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

9.25USD
21 Sep 2018
Change (% chg)

$-0.18 (-1.91%)
Prev Close
$9.43
Open
$9.60
Day's High
$9.60
Day's Low
$9.25
Volume
3,950
Avg. Vol
98,706
52-wk High
$13.54
52-wk Low
$2.60

Chart for

About

TapImmune Inc. is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 10.16
Dividend: --
Yield (%): --

Financials

  TPIV.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -- -- --
ROI: -911.19 1.78 14.61
ROE: -911.19 3.27 16.33

BRIEF-Tapimmune And Marker Therapeutics Announce Entry Into Merger Agreement

* TAPIMMUNE AND MARKER THERAPEUTICS ANNOUNCE ENTRY INTO MERGER AGREEMENT, CREATING A TRANSFORMATIONAL IMMUNO-ONCOLOGY PLATFORM

15 May 2018

BRIEF-Iroquois Capital Management LLC Reports A 5.5 Pct Stake In TapImmune As Of April 4

* IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 5.5 PCT STAKE IN TAPIMMUNE AS OF APRIL 4 - SEC FILING

04 Apr 2018

Earnings vs. Estimates

No consensus analysis data available.